Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals

Vaccine

Volumn 25, Issue 16 SPEC. ISS., 2007, Pages 3133-3136

  Da Villa, Giuliano ^a   Romanò, Luisa ^b   Sepe, Alessio ^a   Iorio, Raffaele ^c   Paribello, Nunzio ^c   Zappa, Alessandra ^b   Zanetti, Alessandro R ^b  

^a Ital Inst for Prev of Liver D   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c ASL Napoli 3 SUD   (Italy)

Author keywords

HBV prevalence; Hepatitis B vaccination; Long term protection

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DATA ANALYSIS; DISEASE CONTROL; FEMALE; HEPATITIS B; HUMAN; IMMUNIZATION; INFANT; ITALY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; VACCINATION;

EID: 33947576357     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.044     Document Type: Article

References (16)

1. Giusti G., Galanti B., and Gaeta G.B. Epidemiology of viral hepatitis B in Italy. Boll Ist Sieroter Milan 59 (1980) 571-580
2. Crovari P. Epidemiology of viral hepatitis in Italy. Vaccine 13 Suppl.1 (1995) S26-S30
3. Pasquini P., Kahn H.A., Pileggi D., Panà A., Terzi J., and Guzzanti E. Prevalence of hepatitis B markers in Italy. Am J Epidemiol 118 (1983) 699-709
4. Da Villa G., Piccinino F., Sagnelli E., De Luca G., and Pasquale G. Prevalenza di casi con positività nel siero dell'antigene Australia (HBsAg) in alcuni campioni di popolazione in Campania. Igiene Moderna 71 (1978) 3-14
5. Utili R., Galanti B., Da Villa G., Andreana A., Felaco F.M., Filippini P., et al. Hyperendemicity of viral hepatitis in the Neapolitan area: an epidemiological study. Boll Ist Sieroter Milan 62 (1983) 145-152
6. Piazza M., Da Villa G., Picciotto L., Abrescia N., Guadagnino V., Memoli A.M., et al. Mass vaccination against hepatitis B in infants in Italy. Lancet 332 (1988) 1132
7. Zanetti A.R., Tanzi E., Romanò L., and Grappasonni I. Vaccination against hepatitis B: the Italian strategy. Vaccine 11 (1993) 521-524
8. Bonanni P. Implementation in Italy of a universal vaccination programme against hepatitis B. Vaccine 13 Suppl.1 (1995) S68-S71
9. Da Villa G., Piazza M., Iorio R., Picciotto L., Peluso P., De Luca G., et al. A pilot model of mass vaccination against hepatitis B virus suitable for mass vaccination campaigns in hyperendemic areas. J Med Virol 36 (1992) 276-278
10. http://www.iss.it/seie
11. Da Villa G., Picciotto L., Elia S., Peluso F., Montanaro F., and Maisto T. Hepatitis B vaccination: universal vaccination of new-born babies and at 12 years of age versus high-risk groups. A comparison in the field. Vaccine 13 (1995) 1240-1243
12. Chan C.Y., Lee S.D., and Lo K.J. Legend of hepatitis B vaccination: the Taiwanese experience. J Gastroenterol Hepatol 19 (2004) 121-126
13. Whittle H.C., Maine N., Pilkington J., Mendy M., Fortuin M., Bunn J., et al. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet 345 (1995) 1089-1092
14. Viviani S., Jack A., Hall A.J., Maine N., Mendy M., Montesano R., et al. Hepatitis B vaccination in infancy in the Gambia: protection against carriage at 9 years of age. Vaccine 17 (1999) 2946-2950
15. Wainwriting R., Bulkow L.R., Parkinson A.J., Zanis C., and Mc Mahon B.J. Protection provided by hepatitis B vaccine in a Yupik Eskimo population: results of a 10 year study. J Infect Dis 175 (1997) 674-677
16. Zanetti A.R., Mariano A., Romanò L., D'Amelio R., Chironna M., Coppola R.C., et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 366 (2005) 1379-1384